Philippine General Hospital
University of the Philippines, Manila
Department of Pediatrics
Section of Pediatric Hematology-Oncology
Daily Census
As of November 30, 2009
Fajardo/ Coniconde/ Serna
B16
B17
B18
B19
B20
B26
SERVICE BEDS
5
SIANQUITO
AVILA
DIZON
MARIBOJO
SANDINO
CAPARAS
PER
CN 2713691
DOA 11/29/09
DOB 4/27/00
W 11
3
B3 AYO
B12 JIMENEZ
B33 ROSALES
PER
3
RIQUE
RIQUE, Marvin
9/ M Wt 26.7
PER
MARIBOJO
PIMENTEL
SALUNA
MALAYON
MARIBOJO
PINILI (11/22)
Patient with recurrent epistaxis
On day of consult, patient had epistaxis
Qualitative PLatelet Defect
SERVICE BEDS
W9 B16
CN 3490264
DOA 11/5/09
DOB 11/3/93
SIANQUITA, Carolyn
16/ F
Wt. 41 kg Ht 160 BSA. 1.35m2
Spinal Cord Compression secondary to
Spindle Cell Tumor
Urinary tract infection secondary to
Neurogenic Bladder
R/O Metastasis
1 month PTA- abdominal mass on LQ of abdomen, consulted
private MD, CT Scan: complex left abdominopelvic mass with
infiltration neural foramina and spinal canal, osteolysis of
the transverse prcess and infiltration of the L iliacus and
iliopsoas muscle. Consideration: neurofibrosarcoma. +
retroperitoneal lymphadenopathy
15 day PTA- px seen at CI OPD; repeat work up was
requested. BMA done: mildly to moderately hypocellular
marrow with trilineage hematopoeisis, no evidence of tumor
involvement
3 days PTA- fever, (+) difficult in urination, vomiting, fecal
incontinence
1 day PTA- in severe pain
DISCHARGED
WARD
CALIMPONG
ESGUERRA
BEDS
SUAREZ
HERNANDEZ
VALENCIA (11/22)
MORTALITY
1
RAMOS (REFERRAL) (9/18?)
SIGNED OUT
Villapando
Abadines
TOS
Maligaya
AB+
CBC
(11/29) 108/ 0.326/ 0.538/ 0.301/ 0.066/ 0.092/ 0.003/ 146
URINALYSIS
(11/19) yellow/ clear/ SG 1.025/ pH 6.5/ CHO (-)/ CHON (-)/ rbc 0-1/
wbc 0-1/ ec (-)/ bact few/ mt occ/ ca oxalate few
For BT of PC 5u q8
B+
CBC
(11/13) 106/ 0.289/ 13.3/ 0.771/ 0.151/ 0.062/ 0.016/ 574
(11/5) 102/ 0.304/ 25.17/ 0.847/ 0.072/ 0.077/ 0.003/ 0.001/ 257
MCV 85.9/ MCH 28.8/ MCHC 336/ RDW 13.8
Normocytic, normochromic, no toxic granulations seen
PT/ PTT
(11/5) 13.1/ 15.7/ 0.65/ 1.5
36.4/ 54.9
BLOOD CHEM
(11/25) BUN 4.28/ crea 41/ Na 137/ K 3.7/ Cl 101
(11/5) Gluc 5.93/ BUN 2.9/ crea 46/ UA 0.14/ alb 24/ TB 1.3/ DB 0.76/
IB 0.55/ alk phos 272/ AST 84/ ALT 24/ Ca 1.99/ Mg 0.96/ Phos 0.79
LDH 1362/ Na 134/ K 3.8/ Cl 97
24 HOUR URINE COLLECTION
(11/9) TV 660/ TP 0.132/ TC 0.730
URINALYSIS
(11/23) yellow/ hazy/ SG 1.01/ pH 8.5/ CHO (-)/ CHON 2+/ rbc 4-6/
wbc 80-90/ ec (-)/ bact 4+/ mt (-)
(11/23) yellow/ turbid/ SG 1.01/ pH 8.5/ CHO (-)/ CHON 2+/ rbc 70-80/
wbc 80-90/ eco cc/ bact 3+/ mt rare/ triple phos few
(11/21) yellow/ turbid/ SG 1.005/ pH 8.5/ CHO (-)/ CHON 1+/ rbc 0-2/
wbc 10-15/ ec (-)/ bact 3+/ mt (-)/ triple phosphate 3+/
(11/5) dark yellow/ sl hazy/ SG 1.020/ pH 7.5/ (-) sugar/ 1+ CHON/
3-7 RBC/ 2-5 WBC/ 0-1 hyaline cast/ few ec/ occ bac/ (-) MT
BLOOD CS
(11/10) NG5D
BMA
(11/2) Mildly to moderately hypocellular marrow with trilineage
hematopoeisis; no evidence of involvement by a tumor
CORE NEEDLE BIOPSY
(11/13) fragments of skeletal muscle, fibrocollagenous tissue ans scanty
For MRI of the spine
For bone scan
For Lumbosacral APL xray
For DMSA
For Urine GS/CS
T/S Tranexamic Acid
Cefuroxime
Morphine SO4
Gabapentine
Paracetamol
Lactulose
T/S Nitrofurantoin
Cpntinue bedside rehab
For chemptherapy using
rhabdomyosarcoma
protocol once with meds
W9 B17
CN
DOA 11/6/09
DOB 7/15/95
W9 B18
CN 3171048
DOA 11/4/09
DOB 4/25/04
AVILA, Patricia
14/ F Wt: 40 kgs
Myelodysplastic Syndrome
R/O AML conversion
CAP, resolved
R/O Fungal Sepsis
DIZON, Gabrielle Ryaine
5/ F
17 kg 110.5 cm BSA 0.72
Ganglioneuroblastoma, posterior
mediastinum Stage IV with Tumor
recurrence
S/P Induction Chemotherapy (OPEC,
OJEC Protocol, 2009)
CAP, resolved
P. putida sepsis, resolved
SVC/SMS ruled out
Patient is a diagnosed case of MDS since April 2008 by BMA
biopsy initially presenting with easy fatigability; onregular ffup c/o HO.
Patient was apparently well until 1 day PTA, patient had
sudden onset of generalized pallor associated with
undocumented fever and colds. Persistence prompted
consult and subsequent admission.
Diagnosed case of ganglioneuroblastoma, posterior
mediastinum, stage II b by excision biopsy at St. Lukes
Hospital 6/14/09, initially presenting with nonproductive
cough and an incidental finding of mass in CXR; no fever, no
weight loss.
Patient completed induction chemotherapy with OPEc-OJEC
protocol (Vincristine, Cisplatin, Etoposide-Vincristine,
Cyclophosphamide,Etoposide, Carboplatin) from September
2007-January 2008. However, reinduction chemotherapy is
contemplated with ICE protocol (ifos, carboplatin, etoposise)
for tumor recurrence which started 3PTA as a mass on the
lateral anterior neck. Last CT Scan of the chest revealed
cervicothoracis paravertebral mass: tumor progression.
Patient was apparently well until
5 days PTA- nonproductive cough, no fever, good appetite;
consult done at OPD; given with Cefuroxime without relief
2 days PTA- (+) weakness in standing up (walang pwersa); no
consult done
1 day PTA- (+)fever on and off Tmax 39.1 PER
spindle cell tumor
KUB UTZ
(11/26) normal UTZ
O+
CBC
(11/28) 47/ 0.146/ 6.9/ 0.786/ 0.146/ 0.058/ 0.007/ 0.003/ 8
(11/23) 73/ 0.231/ 6.93/ 0.69/ 0.18/ 0.05/ 0.01/ stab 0.02/ meta 0.02/
myelo 0.01/ reactive lym 0.03/ plt 209
(11/18) 42/ 0.135/ 5.78/ 0.69/ 0.09/ 0.19/ 0.02/ stab 0.01/ nrbc 30/ 11
(11/14) 55/ 0.193/ 3.34/ 0.515/ 0.332/ 0.114/ 0.033/ 16/ normocytic/
hypochromic/ no TG
(11/9) 75/ 0.237/ 21.4/ 0.52/ 0.27/ 0.02/ 0.03/ 0.01/ 15/ stab 13/ meta 01/
promyelo 01/ NRBC 85/100/ plt 15
(11/6) 48/ 0.156/ 19.66/ 0.36/ 0.536/ 0.066/ 0.007/ 0.031/ 12
BLOOD CHEM
(11/18) Ca 1.84/ Na 139/ K 2.8/ Cl 102
(11/12) Ca 1.97/ Na 133/ K 6.6/ Cl 104
(11/11) ca 2.02/ na 134/ k 4.7/ cl 102
(11/10) ca 1.97/ na 133/ k 6.6/ cl 104
(11/8) ca 1.84/ na 139/ k 2.8/ cl 102
(11/7) BUN 16.4/ crea 132/ Ca 1.89/ Na 133/ K 3/ Cl 96
URINALYSIS
(11/21) amber/ clear/ SG 1.015/ pH 7.5/ CHO (-)/ CHON 2+/ rbc 35-45/
wbc 2-6/ hyphal elements (-)/ eco cc/ bact few/ mt (-)/
coarse gran cast 2-3/ hgb 37
(11/9) dark yellow/ hazy/ SG 1.01/ pH 7.5/ CHO (-)/ CHON 2+/ RBC 3-8/
WBC 0-2/ eco cc/ bact 1+/ mt rare
BLOOD CS
(11/23) NG5D
(11/7) NG5D
CXR CAP
A+
CBC
(11/20) 87/ 0.311/ 9.83/ 0.767/ 0.111/ 0.121/ 0.000/ 0.001/ 227
(11/12) 92/ 0.309/ 10.11/ 0.727/ 0.139/ 0.131/ 0.002/ 0.001/ 544
(11/8) 102/ 0.338/ 12.19/ 0.751/ 0.108/ 0.133/ 0.006/ 742
(11/2) 110/ 0.346/ 13.64/ 0.736/ 0.136/ 0.127/ 0.0/ 0.001/ plt 341
ABG
(11/29) 7.443/ 33.9/ 70/ 23.2/ 0.1/ 94.7
(11/17) 7.433/ 55.6/ 102.9/ 32.5/ 9.9/ __
(11/16) 7.418/ 51.3/ 114.1/ 29.9/ 6.8/ 98.5
(11/15) 7.466/ 46.8/ 159.7/ 31/ 8/ __
(11/12) 7.478/ 42.5/ 84.8/ 26.9/ 2.1/ 96.5
(11/11) 7.41/ 42.5/ 84.8/ 26.9/ 2.1/ 96.5
(11/5) 7.474/ 33.2/ 118.9/ 24.8/ 0.5/ 98.9
BLOOD CHEM
(11/16) ca 2.22/ na 135/ k 4.2/ cl 92
(11/14) bun 1.46/ crea 31/ alb 28/ ca 2.22/ na 137/ k 3.2/ cl 90
(11/12) RBS 3.95/ crea 25/ ua 0.42/ AST 84/ ALT 38/ Ca 2.24/ Mg 0.96/
LDH 855/ Na 135/ K 4.2/ Cl 94
(11/12) plasma K 3.6
(11/2) Gluc 6.29/ BUN 2.89/ crea 42/ UA 0.23/ alb 27/ TB 0.39/ DB 0.08/
IB 0.31/ alk phos 162/ AST 81/ ALT 26/ Ca 2.3 / Mg 0.96/ Phos 1.33
LDH 761/ Na 133/ K 4.4/ Cl 96
PT/PTT
(11/17) 15.2/ 13.4/ 0.8/ 1.15
For Post-BT CBC with PBS
after 3u PRBC
For U/A with RBC
morphology
For Fecalysis with OB
For cytogenetics C/O NIH
Fluconazole (6) D/C
Paracetamol prn
Diphenhydramine prn
IVF: D5 0.3 NaCl (50% FM)
DAT
For BT of pRBC x 2 more
doses
For BT of PC q8
S/p 1u pRBC and 5u PC since
last CBC
For ABG
Repeat CBC
PT/PTT
Neck STAPL
Paracetamol
Glycerine Suppository
Dexamethasone 4mg IV q6
Feeding 100cc/ NGT q4
IVF D5 0.3 NaCl (FM)
ET 4.5 L 15
40% TV 170(10) RR 30
PEEP 5
Referred to Hospice
For possible tracheostomy
W9 B19
CN 2862560
DOA 11/25/09
DOB 10/18/04
W9 B20
CN 3494213
DOA 10/30/09
DOB 10/3/01
MARIBOJO, Jay Ar
5/ M Wt 14.2 kg
Beta-Thalassemia
CAP
R/O Sepsis
In High Output Failure probably
secondary to Anemia
SANDINO, Lyra
8/ F Wt 16.2 kg Ht 112 cm
AML
Patient is a diagnosed case of B-Thalassemia c/o PGH since
2005, presenting qwith pallor and abdominal enlargement.
4 days PTC, (7 days post discharge), patient developed
cough, productive of yellowish sputum associated with
fever, weakenss and difficulty in breathing. Persistence
prompted consult and subsequent admission
3 mos PTA, (+) non-productive cough with no other
associated ssx; no consult done
2 mos PTA, (+) left eye swelling; consulted an
ophthalmologist who prescribed antibiotics with no relief of
symptoms
1 mo PTA, upon ff-up, px advised orbital CT scan; due to
increase in swelling px consulted pgh ophtha hence
admitted; referred to H-O for co-mgt. A> T/C AML based on
CBC results. BMA done; transferred to H-O bed for further
management.
(11/12)
36/ 31.2
(11/2) 11.1/14.5/0.73/1.39 31.3/46.2
URINALYSIS
(11/3) Lt yellow/ clear/ 1.025/ 6.0/ -gluc/ -P/ 0-1 RBC/ 3-6 WBC/ few bact/
occ ec/ occ mt
BLOOD CS
(11/12) NG2D – NG5D
(11/3) NG2D – (+) Psudomonas putida S: Ciprofloxacin
2D ECHO
(11/5) large cystic mass obscuring the aortic arch and slightly compressing
the left side of the heart; mild TR, mild MR; EF 82%, FS 49.3%
A+
CBC
(11/28) 100/ 0.296/ 1.75/ 0.35/ 0.13/ 0.02/ 51 50 cells counted
(11/26) 65/ 0.19/ 2.22/ 0.419/ 0.486/ 0.081/ 0.009/ 0.005/ 59
(11/26) 55/ 0.165/ 1.94/ 0.402/ 0.495/ 0.098/ 0.000/ 0/.005/ 50
ABG
(7/27) 7.424/ 25.3/ 163.6/ 16.5/ -6.4/ 99.1
BLOOD CHEM
(11/29) BUN 3.93/ crea 31/ AST 114/ ALT 89/ Ca 1.94/ Na 129/ K 3.1/ Cl 96
URINALYSIS
(11/26) yellow/ clear/ SG 1.03/ pH 5.0/ CHO (-)/CHON (-)/ rbc (-)/ wbc 0-1/
Ec few/ bact rare/ mt (-)
A+
CBC
(11/27) 96/ 0.287/ 11.56/ 0.16/ 0.57/ 0.01/ promyelo 0.02/ blast 30/ plt 33
(11/24) 96/ 0.299/ 11.03/ 0.45/ 0.23/ 0.03/ stab 0.02/ blast 27/ plt 31
(11/21) 79/ 0.246/ 8.05/ 0.19/ 0.58/ 0.02/ blast 21/ 47
(11/7) 85/ 0.257/ 22.08/ 0.1/ 0.29/ 0.01/ myelo 0.02/ blast 0.58/ plt 44/
hypochromic/ slight poikilo/ aniso (+)
(11/2) 89/ 0.259/ 34.36/ 0.04/ 0.19/ 0.01/0.01/ myelo 0.03/ blast 0.7/
atyp lym 0.02/ hypochromic/ anisocytosis (+)/ poikilo (+)/ no TG
(11/1) 91/ 0.299/ 24.9/ 0.18/ 0.37/ 0.07/ blast 0.38/ 49/ hypochromic/
anisocytosis (+)/ poikilocytosis (+)/ no TG
(10/30) 85/ 0.248/ 11.9/ 0.434/ 0.529/ 0.033/ 0.002/ 0.002/ 38
(10/29) 86/ 0.259/ 15.46/ 0.16/ 0.68/ 0.02/ myelo 0.01/ blast 0.13/ plt45
BLOOD CHEM
(11/27) bun 2.48/ crea 44/ UA 0.24/ alb 38/ TB 0.25/ DB 0.05/ IB 0.19/
alk phos 103/ ast 23/ alt 40/ ca 2.19/ mg 0.84/ ldh 214/ Na 142/
K 3.3/ Cl 102
(11/7) rbs 4.71/ bun 3.89/ crea 48/ alk phos 103/ na 137/ k 3.9/ cl 100
(10/30) UA 0.25/ alk phos 117/ ast 16/ alt 29/ ca 2.41/ phos 1.8/ ldh 193
(10/30) bun 3.77/ crea 43/ na 140/ k 3.9/ cl 102
URINALYSIS
(11/27) lt yellow/ clear/ SG 1.01/ pH 6.5/ CHO (-)/ CHON (-)/ rbc 0-2/
wbc 0-1/ ec (-)/ bact rare/ mt (-)
(11/7) yellow/ clear/ SG 1.025/ PH 6.5/ CHO (-)/ CHON trace/ rbc 0-1/
wbc 0-1/ eco cc/ bact rare/ mt rare
(10/30) yellow/ clear/ SG 1.03/ pH 6/ CHO (-)/ CHON (-)/ rbc 0-1/ wbc 0-1/
ec (-)/ bact rare/ mt (-)
BLOOD CS
(11/4) NG5D
BMA
Repeat CXR
Ff-up final Blood CS
Shift Cefuroxime to
Ceftazidime (100)
Amikacin (15)
Diphenhydramien
Paracetamol
DAT
IVF: D5 0.3 NaCl
O2 support 10 lpm FM
PNSS neb q2
Dopamine (10)
Dobutamine (8)
For 24 hr urine collection for
TV, TP, TC
Erythromycin eye ointment
Multivitamins
Paracetamol prn
s/p BT 1 unit pRBC
For chemotherapy once
with meds
W9 B26
CN 3406137
DOA 11/23/09
DOB 9/25/08
CAPARAS, Kyle
1/ M Wt: 4.75 kg Ht 83 cm BSA 0.47
m2
Beta Thalassemia
Febrile Neutropenia
CAP
R/O Sepsis
INTRDEPARTMENTAL REFERRALS
W11(14a) B3
AYO ,Randy
CN 1976844
16/M
DOA 9/14/09
DOB 9/27/91
Hemophilia A, moderate
(iliopsoas bleed )
Cholecytolithiasis , Urolithiasis
CN
DOA 11/10/09
DOB
JIMENEZ, Jerome
12/M WT. 20.6 kg
Clinical Nosocomial Sepsis, Resolving
Abscess of Comon Bile Duct and
Gallbladder secondary to Obstructive
jaundice secondary to Biliary Ascariasis
S/P Cholecystectomy, CBDE, T-tube (OM
2/06)
T/C Beta Thalassemia
R/O Chronic Liver DIsease
Anemia probably secondary to Betathalassemia
Malignancy
URTI, bacterial
PEM
W11 B33
CN
DOA 11/11/09
DOB
ROSALES, Mac Ruvic
4months/M 6.7kg 63cm 0.34m2
Intraabdominal Mass, probably
Hepatoblastoma
CAP, resolved
Indirect Inguinal Hernia, Left
Sepsis ruled out
Patient is a diagnosed case of Beta-Thalassemia since 7
months old presenting with pallor. Hgb electrophoresis
done confirmed diagnosis. Since then patient is on regular
follow-up c/o Hema-Onco service.
Patient was apparently well until 1 week PTA when patient
was noted to have productive cough. No consult done.
1 day PTAm patient developed low-grade fever associated
with oral ulcer. Consult done c/o H-O OPD where Hgb 53.
Patient advised admission.
Diagnosed case of hemophilia A
Patient with history of GB removal (?) in 2005 due to
obstruction
2 months PTA, patient noted with jaundice; no consult done
3 days PTA, patient developed fever partially lysed with
paracetamol
1 day- patient with decreased appetite and weakness
prompting consult and subsequent admission
Patient has been admitted because of jaundice and pallor.
T/C Beta Thalassemia.
Patient was sent home apparently well until 2 days after
discharge, there was note of fever undocumented
associated with cough.
Persistence associated with poor appetite and note of
abdominal enlargement  consult admitted
Born FT to a 19 y/o at Catarman Hospital assisted by MD; (+)
PNCU at LHC, ?x starting at 4 months AOG; (+) MV FeSO4; (-)
maternal illness, occasional colds. At birth, good cry. Good
suck and activity.
4 months PTA- abdominal mass R side, no consult
1 month PTA- still with the gradually enlarging abdomen, (+)
cough; consulted UTZ—hepatoblastoma Right lobe
2week PTA- (+) recurrence of cough admission
(11/24) immunologic findings consistent with a blast population of myeloid
lineage
A+
CBC
(11/27) 133/ 0.388/ 5.24/ 0.4/ 0.437/ 0.151/ 0.006/ 0.006/ 113
(11/24) 68/ 0.202/ 5.07/ 0.444/ 0.453/ 0.095/ 0.002/ 0.006/ 72
URINALYSIS
(11/25) yellow/ clear/ SG 1.02/ pH 5.5/ CHO (-)/ CHON (-)/ rbc 0-2/ wbc 1-3/
ec (-)/ bact few/ mt (-)
BLOOD CS
(11/24) NG5D
Ceftazidime (100) D4+1/7
Amikacin (`15) D4
Nystatin
Paracetamol
For home once antibiotics
completed for 7 days
O+
CBC
(11/4) 107/ 0.334/ 5.3/ 0.59/ 0.34/ 0.04/ 0.02/ 239
PT/PTT
(11/4) 12.8/ 12.3/ 1/ 1.18
36.3/ 94.8/ 2.61
URINALYSIS
(10/22) yellow/ clear/ 1.025/ ph 7/ cho (-)/ chon 1+/ rbc 2-6/ wbc 0-1/
ec (-)/ bact few/ mt occ
(10/4) yellow/ , 1.01, pH 8.5 (-) sugar CHON 2+ , RBC 2.6 , WBC 0-2 , EC (-)/
bact few / rare MT , RBC 30% normal , 30% dysmorphic
ILIOPSOAS BLEED
(11/27) 213cc from 273 cc
(10/28) decreasing size
B+
CBC
(11/25) 120/ 0.353/ 6.05/ 0.796/ 0.116/ 0.081/ 0.005/ 0.002/ 136
(11/24) 94/ 0.292/ 4.44/ 0.782/ 0.181/ 0.011/ 0.021/ 0.005/ 128
(11/23) 71/ 0.224/ 8.86/ 0.81/ 0.134/ 0.046/ 0.009/ 0.001/ 175
(11/20) 98/ 0.323/ 11.11/ 0.834/ 0.089/ 0.062/ 0.013/ 0.002/ 188
PT/PTT
(11/24) 38.2/ 33
(11/22) 12.4/ 14.5/ 69%/ 1.27
BLOOD CHEM
(11/28) tb 10.14/ db 9.45/ ib 0.69
(11/25) rbs 9.08/ alb 19/ tb 15.2/ db 12.9/ ib 2.2/ ast 145/ alt 103/ na 140/
k 2.4/ cl 100
(11/20) rbs 6.74/ BUN 2.76/ crea 38/ UA 0.13/ alb 19/ TB 11.8/ DB 9.9/
IB 1.9/ alk phos 467/ AST 31/ ALT 67/ Ca 1.87/ Mg 0.84/ Phos 0.84
Na 142/ K 3.5/ Cl 108
URINALYSIS
(11/20) yellow/ clear/ SG 1.005/ pH 5.5/ CHO (-)/ CHON (-)/ rbc (-)/ wbc (-)/
ec (-)/ bact occ/ mt (-)
ABDOMINAL CT
(11/25) Minimal ascites; splenomegaly
For perlvic UTZ weekly
B+
CBC
(11/16) 96/ 0.298/ 11.6/ 0.354/ 0.518/ 0.013/ 0.115/ 193
(11/11) 116/ 0.353/ 25.58/ 0.26/ 0.60/ 0.08/ 0.03/ 0.01/ myel 0.01/
pro 0.01/ 583
PT/PTT
(11/11) 13.1/11.8/>1/1.13
36.7/38.9
BLOOD CHEM
UTZ guided liver biopsy if
mass is nonresectable
BAER
2D Echo
CT guided aspiration biopsy
c/o Radio
For BT of 23y cryoppt/
factor VIII
For EGD
For Liver Biopsy
For Protein C and S
For osmotic fragility test 15
days from last BT
For Hgb Electrophoresis 2
mons from last BT
Ciprofloxacin
Ibuprofen
Vit K
Pb
UDCA
Clusivol
Vit E
For Alb transfusion
Cefuroxime (100) D14 –d/c
(11/11) Glu 5.25, BUN 1.8, Cre 30, Alb 32, TB 0.25, DB 0.09, IB 0.17, AST 26,
LT 29, Ca 2.29, LDH 172, Na 129, K 4.9 Cl 93
BLOOD CS
(11/11) NG5D
24 HR URINE
(11/27) tv 300 tc 0.043/ tp 0.21
WHOLE ABD UTZ
(11/13) hepatic focus, primary consideration is hepatoblastoma, minimal to
moderate complicated ascites; normal GBSKUB
BHCG
(11/18) < 0.08 low
AFP
(11/25) 39.3
(11/11) 74.95 increased
Salbutamol neb q4
Breastfeeding with SAP`